CD86 and atherosclerosis: In atherosclerosis research, Buono et al. demonstrated that LDL receptor (Ldlr) knockout (KO) mice lacking CD80 and CD86 displayed a delayed atherosclerosis progression compared to control Ldlr KO mice [5].